• Profile
Close

Dosimetric comparison of rectal-sparing capabilities of rectal balloon vs injectable spacer gel in stereotactic body radiation therapy for prostate cancer: Lessons learned from prospective trials

Medical Dosimetry Aug 24, 2017

Jones RT, et al. – Researchers undertook this study to compare the rectal–sparing capabilities of rectal balloons vs absorbable injectable spacer gel in stereotactic body radiation therapy (SBRT) for prostate cancer. The injectable spacer gel outperformed the rectal balloon in the majority of the examined and relevant dosimetric rectal–sparing parameters, in this analysis of patients enrolled on 2 consecutive multi–institutional prospective trials of SBRT for prostate cancer. The data showed that rectal balloon did not outperform the injectable spacer gel in any measured rectal dose parameter.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay